Literature DB >> 15386655

Health state values for the HUI 2 descriptive system: results from a UK survey.

Christopher McCabe1, Katherine Stevens, Jennifer Roberts, John Brazier.   

Abstract

This paper reports the results of a study to estimate a statistical health state valuation model for a revised version of the Health Utilities Index Mark 2, using Standard Gamble health state preference data. A sample of 51 health states were valued by a sample of the 198 members of the UK general population. Models are estimated for predicting health state valuations for all 8000 states defined by the revised HUI2. The recommended model produces logical and significant coefficients for all levels of all dimensions in the HUI2. These coefficients appear to be robust across model specifications. This model performs well in predicting the observed health state values within the valuation sample and for a separate validation sample of health states. However, there are concerns over large prediction errors for two health states in the valuation sample. These problems must be balanced against concerns over the validity of using the VAS based health state valuation data of the original HUI2 valuation model.

Entities:  

Mesh:

Year:  2005        PMID: 15386655     DOI: 10.1002/hec.925

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  26 in total

1.  Deriving a preference-based measure for cancer using the EORTC QLQ-C30.

Authors:  Donna Rowen; John Brazier; Tracey Young; Sabine Gaugris; Benjamin M Craig; Madeleine T King; Galina Velikova
Journal:  Value Health       Date:  2011 Jul-Aug       Impact factor: 5.725

2.  How consistent are health utility values?

Authors:  Pedro L Ferreira; Lara N Ferreira; Luis N Pereira
Journal:  Qual Life Res       Date:  2008-08-08       Impact factor: 4.147

3.  Constructing indirect utility models: some observations on the principles and practice of mapping to obtain health state utilities.

Authors:  Christopher McCabe; Richard Edlin; David Meads; Chantelle Brown; Samer Kharroubi
Journal:  Pharmacoeconomics       Date:  2013-08       Impact factor: 4.981

Review 4.  Valuing health States for use in cost-effectiveness analysis.

Authors:  John Brazier
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

5.  An assessment of the construct validity of the CHU9D in the Australian adolescent general population.

Authors:  Julie Ratcliffe; Katherine Stevens; Terry Flynn; John Brazier; Michael Sawyer
Journal:  Qual Life Res       Date:  2011-08-12       Impact factor: 4.147

6.  Parental Health Spillover in Cost-Effectiveness Analysis: Evidence from Self-Harming Adolescents in England.

Authors:  Sandy Tubeuf; Eirini-Christina Saloniki; David Cottrell
Journal:  Pharmacoeconomics       Date:  2019-04       Impact factor: 4.981

7.  Modelling a preference-based index for EQ-5D using a non-parametric Bayesian method.

Authors:  Samer A Kharroubi; Chaza Abou Daher
Journal:  Qual Life Res       Date:  2018-07-14       Impact factor: 4.147

8.  Modelling a preference-based index for EQ-5D-3L and EQ-5D-3L + Sleep using a Bayesian framework.

Authors:  Samer A Kharroubi; Yara S Beyh; John Brazier; Yaling Yang
Journal:  Qual Life Res       Date:  2020-02-03       Impact factor: 4.147

9.  Preference-Based Health-Related Quality of Life Outcomes Associated with Preterm Birth: A Systematic Review and Meta-analysis.

Authors:  Stavros Petrou; Natnaree Krabuanrat; Kamran Khan
Journal:  Pharmacoeconomics       Date:  2020-04       Impact factor: 4.981

10.  Feasibility, Validity and Differences in Adolescent and Adult EQ-5D-Y Health State Valuation in Australia and Spain: An Application of Best-Worst Scaling.

Authors:  Kim Dalziel; Max Catchpool; Borja García-Lorenzo; Inigo Gorostiza; Richard Norman; Oliver Rivero-Arias
Journal:  Pharmacoeconomics       Date:  2020-05       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.